US · IEX · INDUSTRIAL - MACHINERY
IDEX Corporation (IEX) intrinsic value and stock valuation
$219.64as of 2026-11-21 · Mkt cap 17.28B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
IDEX Corporation DCF and intrinsic value
InvestorsCraft values IEX with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from IEX’s statements →
IDEX Corporation Graham Number
Graham Number: $87.86d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- ITT Inc. (ITT) $201.09
- WESCO International, Inc. (WCC) $282.04
- Nordson Corporation (NDSN) $307.22
- Lincoln Electric Holdings, Inc. (LECO) $250.36
- Graco Inc. (GGG) $69.39
- CNH Industrial N.V. (CNH) $10.74
- Watts Water Technologies, Inc. (WTS) $345.78
- Crane Company (CR) $202.13
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.46B | $3.27B | $3.27B | $3.18B | $2.76B |
| Operating income | $720M | $696.9M | $750.7M | $789.5M | $654M |
| Net income | $483.2M | $505M | $596.1M | $586.9M | $449.4M |
| EPSd | $6.42M | $6.65M | $7.85M | $7.72M | $5.88M |
| Operating cash flow | $680.4M | $668.1M | $716.7M | $557.4M | $565.3M |
| Capital expenditure | -$-63.6M | -$-65.1M | -$-89.9M | -$-68M | -$-72.7M |
| Free cash flow | $616.8M | $603M | $626.8M | $489.4M | $492.6M |
| Total assets | $6.93B | $6.75B | $5.87B | $5.51B | $4.92B |
| Total debt | $1.85B | $1.99B | $1.45B | $1.59B | $1.3B |
| Net debt | $1.27B | $1.37B | $911.5M | $1.16B | $445.9M |
| Total equity | $4.03B | $3.79B | $3.54B | $3.04B | $2.8B |
| Cash and short-term investments | $580M | $620.8M | $534.3M | $430.2M | $900.7M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.46B | $3.27B | $3.27B | $3.18B | $2.76B |
| Cost of revenue | $1.92B | $1.75B | $1.65B | $1.59B | $1.4B |
| Gross profit | $1.54B | $1.52B | $1.62B | $1.59B | $1.36B |
| Research and development expenses | $0.00 | $178.6M | $175.9M | $156.8M | $133M |
| Selling, general and administrative expenses | $818.8M | $749M | $696.2M | $648.1M | $573.2M |
| Other expenses | $0.00 | -$-107.8M | $0.00 | $0.00 | $1.3M |
| Operating expenses | $818.8M | $819.8M | $872.1M | $804.9M | $707.5M |
| Cost and expenses | $2.74B | $2.57B | $2.52B | $2.39B | $2.11B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $64.4M | $44.5M | $51.7M | $40.7M | $37.7M |
| Depreciation and amortization | $206.5M | $175.6M | $152.1M | $119.7M | $103M |
| Ebitda | $903.5M | $859.4M | $964.1M | $909.8M | $720.5M |
| Operating income | $720M | $696.9M | $750.7M | $789.5M | $654M |
| Total other income/expenses, net | -$-87.4M | -$-57.6M | $9.6M | -$-40.1M | -$-74.2M |
| Income before tax | $632.6M | $639.3M | $760.3M | $749.4M | $579.8M |
| Income tax expense | $150.1M | $134.7M | $164.7M | $162.7M | $130.5M |
| Net income | $483.2M | $505M | $596.1M | $586.9M | $449.4M |
| Weighted average shares outstanding | $75.3M | $75.7M | $75.6M | $75.7M | $76M |
| Weighted average diluted shares outstanding | $75.3M | $75.9M | $75.9M | $76M | $76.4M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $580M | $620.8M | $534.3M | $430.2M | $900.7M |
| Net receivables | $521.7M | $465.9M | $427.8M | $442.8M | $356.4M |
| Inventory | $479.4M | $429.7M | $420.8M | $470.9M | $370.4M |
| Total current assets | $1.64B | $1.59B | $1.45B | $1.4B | $1.68B |
| Property, plant and equipment, net | $587.7M | $585.6M | $548.6M | $382.1M | $327.3M |
| Goodwill and intangible assets | $4.66B | $4.54B | $3.85B | $3.59B | $2.77B |
| Long-term investments | $2.9M | $0.00 | -$-291.9M | $300K | $100K |
| Total non-current assets | $5.28B | $5.15B | $4.42B | $4.11B | $3.24B |
| Total assets | $6.93B | $6.75B | $5.87B | $5.51B | $4.92B |
| Accounts payable | $224.7M | $197.8M | $179.7M | $208.9M | $178.8M |
| Short-term debt | $28.5M | $126.8M | $22.6M | $21.6M | $17.6M |
| Deferred revenue | $45.8M | $50.7M | $55.9M | $44.7M | $49M |
| Total current liabilities | $575.4M | $629.7M | $500.3M | $543.6M | $480M |
| Long-term debt | $1.82B | $1.86B | $1.42B | $1.57B | $1.28B |
| Deferred revenue, non-current | $0.00 | $13.2M | $17.3M | $15M | $32.2M |
| Total non-current liabilities | $2.33B | $2.32B | $1.82B | $1.93B | $1.63B |
| Capital lease obligations | $27.8M | $26.1M | $120.1M | $118.2M | $111M |
| Total liabilities | $2.9B | $2.95B | $2.32B | $2.47B | $2.11B |
| Common stock | $900K | $900K | $900K | $900K | $900K |
| Retained earnings | $4.5B | $4.23B | $3.93B | $3.53B | $3.13B |
| Accumulated other comprehensive income (loss) | $57.6M | -$-130.9M | -$-45.8M | -$-126.2M | -$-69.6M |
| Total equity | $4.03B | $3.79B | $3.54B | $3.04B | $2.8B |
| Total investments | $2.9M | $0.00 | -$-291.9M | $300K | $45.4M |
| Total debt | $1.85B | $1.99B | $1.45B | $1.59B | $1.3B |
| Net debt | $1.27B | $1.37B | $911.5M | $1.16B | $445.9M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $482.5M | $504.6M | $595.6M | $586.7M | $449.3M |
| Depreciation and amortization | $206.5M | $175.6M | $152.1M | $119.7M | $103M |
| Stock-based compensation | $27.3M | $25.8M | $21.8M | $21.6M | $20.4M |
| Change in working capital | -$-49.4M | -$-17M | $32.8M | -$-135.4M | -$-18M |
| Accounts receivable | -$-41.2M | -$-16.9M | $20.5M | -$-71.7M | -$-49.4M |
| Inventory | -$-34.2M | $17.6M | $66.2M | -$-72.4M | -$-46.1M |
| Accounts payable | $15.2M | $8.9M | -$-25.3M | $17.6M | $22.9M |
| Net cash provided by operating activities | $680.4M | $668.1M | $716.7M | $557.4M | $565.3M |
| Investments in property, plant and equipment | -$-63.6M | -$-65.1M | -$-89.9M | -$-68M | -$-72.7M |
| Acquisitions, net | -$-76.2M | -$-939.4M | -$-193.2M | -$-896.2M | -$-577.4M |
| Net cash used for investing activities | -$-137.6M | -$-1.01B | -$-283.8M | -$-917.2M | -$-698.1M |
| Common stock issued | $0.00 | $16.7M | $21.5M | $14.1M | $13.6M |
| Common stock repurchased | -$-247.8M | $0.00 | -$-24.2M | -$-148.1M | $0.00 |
| Dividends paid | -$-212.6M | -$-205.3M | -$-190.7M | -$-177.4M | -$-161.1M |
| Net cash used for financing activities | -$-632.6M | $465.9M | -$-344.7M | -$-37.8M | -$-9.5M |
| Net change in cash | -$-53M | $104.6M | $104.1M | -$-425.2M | -$-170.5M |
| Cash at end of period | $585.9M | $638.9M | $534.3M | $430.2M | $855.4M |
| Operating cash flow | $680.4M | $668.1M | $716.7M | $557.4M | $565.3M |
| Capital expenditure | -$-63.6M | -$-65.1M | -$-89.9M | -$-68M | -$-72.7M |
| Free cash flow | $616.8M | $603M | $626.8M | $489.4M | $492.6M |
Line items
Line items
Line items
About IDEX Corporation
IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications. This includes advanced fluidic devices, various types of pumps (rotary lobe, centrifugal, positive displacement), roll compaction and drying technologies, pneumatic components, and sealing solutions, as well as biocompatible medical devices, optical components, and precision photonic solutions. Key markets for this segment encompass food and beverage, pharmaceutical, cosmetics, marine, chemical, wastewater treatment, life sciences, research, and defense. Finally, the FSDP segment delivers critical equipment for emergency services, such as firefighting pumps, valves, rescue tools, and lifting bags. It also provides engineered stainless steel banding and clamping devices for industrial and commercial use, alongside specialized precision equipment for dispensing, metering, and mixing colorants and paints for retail and commercial clients. IDEX Corporation was founded in 1987 and maintains its headquarters in Northbrook, Illinois.
- CEO
- Eric D. Ashleman
- Employees
- 8.7K
- Beta
- 0.97
Included in
Explore
Frequently asked questions
What is the intrinsic value of IDEX Corporation (IEX)?
IDEX Corporation (IEX) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is IEX undervalued?
IEX trades at a price of $219.64 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.